mm FYI

Tamar Hosansky

Freedom of Speech


The FDA has lost again--and pharmaceutical companies now have more wiggle room to promote off-label uses of drugs and medical devices. In a recent decision, U.S. District Court Judge Royce C. Lamberth denied the FDA's motion to amend his July 1998 ruling curtailing the agency's power to regulate the drug industry.

In his original decision on the lawsuit brought by the Washington Legal Foundation, a nonprofit or

Register to view the full article

Register for and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.